Greater Philadelphia – Regional Life Sciences Roundup – November 5, 2026
This week in Greater Philadelphia, growth came from adding to what was already working. Instead of starting from scratch, companies brought in the technology, partners, and people that could take an existing business further.
The biggest deals made that clear. Agilent agreed to acquire Proscia for up to $270 million, bringing its AI-enabled digital pathology platform under one roof with a long-time partner. Audubon-based Globus Medical acquired Synaptive Medical, adding surgical planning, navigation, and visualization technology to a cranial neurosurgery business it had already built. And INOVIO received FDA accelerated approval for VOCERYQ™, moving an immunotherapy for recurrent respiratory papillomatosis toward a commercial launch in early 2027.
The same thinking showed up across the region’s teams and facilities. Made Scientific named James Leba to lead technical operations across its New Jersey and Pennsylvania sites as it prepares for new manufacturing programs. Uniquity Bio brought on Dr. Nikhil Mehta as an advisor ahead of potential late-stage development. And BioPharmaSpec nearly tripled its Malvern lab, adding room for instruments and the people to run them.
Globus Medical isn’t just buying capabilities. It’s hiring for them too, with 177 open roles across the region right now.
Financial
Tracking the capital moving through Greater Philadelphia: funding rounds, M&A activity, and investment trends shaping Philadelphia, Southern New Jersey, and Delaware’s life sciences companies.
Agilent to AcquireProscia in Deal Worth Up to $270 Million, Expanding AI-Enabled Digital Pathology
Agilent Technologies agreed to acquire Philadelphia-based digital pathology software provider Proscia for up to $270 million. The all-cash transaction includes $240 million at closing and up to $30 million more tied to future performance milestones. Read More >
Medicus Pharma Announces Proposed SkinJect® Business Combination and Concurrent Financing
Philadelphia-based Medicus Pharma entered into a non-binding letter of intent with an undisclosed SPAC for a proposed business combination involving its subsidiary SkinJect, which develops a dissolvable microneedle patch to deliver doxorubicin into basal cell carcinoma lesions. Medicus intends to retain majority ownership while establishing SkinJect as a separately Read More >
Penn-BioNTech Innovative Therapeutics Seed Fund Announces First Investment
The Penn-BioNTech Innovative Therapeutics Seed Fund invested in Emvena Therapeutics, its first company, which is developing placenta-targeted mRNA medicines for maternal and fetal conditions. The Philadelphia-based company is advancing technology from University of Pennsylvania researcher Michael J. Mitchell that uses lipid nanoparticles to deliver mRNA directly to the placenta Read More >
Foundational gift accelerates Penn Medicine brain tumor research and care
Penn Medicine established the Troiano Brain Tumor Center with a foundational gift from John Gabriele Troiano and Rosanna Troiano. Combined with institutional investment and additional philanthropy, the gift launches a $35 million initiative supporting brain tumor research and care. Read More >
Globus Medical: Acquires Synaptive Medical, Strengthening Its Position in Cranial Neurosurgery
Audubon, Pennsylvania-based Globus Medical announced its acquisition of Synaptive Medical, adding surgical planning, visualization, navigation, and magnetic resonance imaging technologies. The acquisition closed on August 4, 2026, through a court-appointed receivership process; Globus announced it on November 3. Read More >
People
Who we’re buzzing about this week: the leadership moves, board appointments, and rising names shaping the region’s life sciences community.
Melissa Callum Joins the Philadelphia Convention and Visitors Bureau as Executive Director of PHL Life Sciences
Melissa Callum joined the Philadelphia Convention and Visitors Bureau as executive director of PHL Life Sciences. She brings more than a decade of experience and will connect meeting organizers with Philadelphia’s medical and life sciences community. Read More >
James Leba to Made Scientific as Vice President and Head of Technical Operations
Made Scientific named James Leba vice president and head of technical operations across its Princeton, New Jersey, and East Norriton, Pennsylvania, sites. He brings more than 13 years of cell therapy experience and will help teams prepare for new manufacturing programs. Read More >
Uniquity Bio Welcomes Dr. Nikhil Mehta as Advisor to the Company and its Board of Directors
Malvern, Pennsylvania-based Uniquity Bio appointed Nikhil Mehta as an advisor to the company and its board of directors. He brings more than 25 years of regulatory, development, and manufacturing experience as Uniquity prepares for potential late-stage development of solrikitug. Read More >
Workforce
The hiring activity, team expansions, and talent trends driving growth across Philadelphia, New Jersey, and Delaware life sciences and biotech employers.
Your Guide to a Career in Biopharma Manufacturing
BioBuzz’s biopharma manufacturing career guide examines the work behind producing vaccines, biologics, and personalized cell therapies consistently and at scale. It covers required competencies, career paths, and organizations building the regional talent pipeline. Read More >
The Catalyst Fund
Philadelphia’s Small Business Catalyst Fund offers grants of up to $50,000 and advisory services to eligible businesses seeking to expand capacity. Applicants must demonstrate growth potential and meet requirements covering revenue, registration, taxes, and operating history. Read More >
Emergent Ventures Grant Application
Emergent Ventures accepts grant applications from people age 13 and older worldwide for ideas advancing positive social change. Funding is project specific, proposals must stand alone within 1,500 words, and artificial intelligence use is permitted only for proofreading. Read More >
Who’s Hiring
Who’s HiringTOP EMPLOYER |
||||||
|
||||||
| View all jobs on BioBuzz |
Clinical + Commercial
The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across Greater Philadelphia.
Fox Chase Cancer Center Researchers Identify Potential New Target for Pancreatic Cancer
Philadelphia’s Fox Chase Cancer Center researchers identified anoctamin 6, or ANO6, as a potential target for pancreatic cancer research. Their preclinical work examined blocking the protein and its relationship to tumor growth and immune suppression. Read More >
Iovance Reports Updated IOV-LUN-202 Results and Adds Precision TIL Strategy for Second-Line Metastatic Non-Small-Cell Lung Cancer (mNSCLC)
Iovance reported updated IOV-LUN-202 results and added a precision tumor-infiltrating lymphocyte strategy for second-line metastatic non-small-cell lung cancer. Read More >
INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP)
INOVIO announced that the Food and Drug Administration granted accelerated approval to VOCERYQ™ for adults with recurrent respiratory papillomatosis. The company expects ordering and shipping to begin in approximately 60 days, with a full commercial launch in the first quarter of 2027. Read More >
Ecosystem
The partnerships, programs, and policy moves building Greater Philadelphia’s life sciences infrastructure, and the organizations driving it forward.
Signant Health Introduces Signant SignalSpace™, a Connected Environment for Clinical Trial Data and Workflows
Signant Health introduced Signant SignalSpace™, which the company describes as a connected environment for clinical trial data and workflows. The announcement concerns the company’s work in evidence generation for clinical trials. Read More >
Pelthos Therapeutics to Combine with Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases that Affect the Skin
Pelthos Therapeutics announced plans to combine with Castle Creek Biosciences, creating a biotechnology company focused on serious diseases affecting the skin. The proposed combination includes Castle Creek’s late-stage D-Fi franchise targeting rare diseases. Read More >
BioPharmaSpec Opens the Doors to Its Expanded Malvern Lab, Inviting Greater Philadelphia’s Life Sciences Community Inside
BioPharmaSpec welcomed the regional life sciences community to its expanded Malvern, Pennsylvania, laboratory on October 20. Its only S. lab grew from just over 4,000 square feet to more than 11,000, adding space for instrumentation and staff. Read More >
Prosoft and AMS Advanced Medical Services Announce an Agreement to Form a Global, Full-Service CRO
Prosoft Clinical and AMS Advanced Medical Services announced an agreement in October 2025 to form a global, full-service contract research organization. Prosoft would lead North American operations, with AMS investing through its S. subsidiary and planning additional investments toward integration. Read More >
Other [Good] Reads
Editor’s picks from across the web: the stories, videos, and podcasts shaping the conversation in PHL biotech and life sciences this week.
Biologics Testing Trends: Insights from Analytical Experts
Analytical experts discuss trends in biologics testing. Read More >
Construct Viability: A Hidden Challenge in Viral Vector Manufacturing
Minaris examines how viral vector designs can encounter manufacturing obstacles as programs approach an Investigational New Drug filing. The company highlights early construct viability checks as a way to identify problems before teams face delays and redesigns. Read More >
On the Calendar
A few of the upcoming events, conferences, and networking opportunities across Greater Philadelphia’s life sciences ecosystem that you don’t want to miss.
Patient Advocacy Summit
Tuesday, November 10 · Philadelphia, PA
BioBreakfast De Museum of Nature & Science
Thursday, November 12 · 2:30 AM · Philadelphia, PA, Seminar / Talk / Lecture
Safety, Translation, and Real-World Implementation of AAV and LNP Gene Therapies
Friday, November 20 · 2:30 AM · Philadelphia, PA, Workshop / Training / Class
Did we miss something!? Drop us a line →
Stay connected to Greater Philadelphia’s life sciences.
